StonvexLoading…
StonvexStonvexStonvexCore line items from UI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-06-30 | Annual 2024 2024-06-30 | Annual 2023 2023-06-30 | Annual 2022 2022-06-30 |
|---|---|---|---|---|
Revenue | $2.57B | $1.93B | $1.94B | $1.69B |
Operating Income | $836.28M | $499.00M | $544.57M | $462.26M |
Net Income | $711.92M | $349.96M | $407.64M | $378.66M |
EPS (Diluted) | $11.76 | $5.79 | $6.74 | $6.13 |
Total Assets | $1.47B | $1.15B | $1.41B | $844.71M |
Total Liabilities | $798.19M | $1.06B | $1.52B | $1.23B |
Cash & Equivalents | $149.73M | $126.34M | $114.83M | $136.22M |
Free Cash Flow OCF − CapEx | $627.44M | $529.54M | $-166.36M | $356.79M |
Shares Outstanding | 60.49M | 60.46M | 60.44M | 60.42M |